{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T19:22:39Z","timestamp":1790709759686,"version":"4.1.0"},"reference-count":52,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T00:00:00Z","timestamp":1783382400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Nutr."],"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>The association between non-high-density lipoprotein cholesterol to high-density lipoprotein cholesterol ratio (NHHR) and prognosis in patients with end-stage renal disease (ESRD) remains controversial. The aim of this study is to explore the association of NHHR with cardiovascular disease (CVD) mortality as well as all-cause mortality in peritoneal dialysis (PD) patients.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>In this single-center prospective observational cohort study, 1,616 individuals undergoing PD were recruited with a median follow-up duration of 47.6\u202fmonths. The association of NHHR with overall CVD mortality, as well as atherosclerotic and non-atherosclerotic subtypes, was assessed using competing risk regression models. Additionally, multivariable Cox proportional hazards regression was employed to evaluate the relationship between NHHR and all-cause mortality. Critical baseline covariates were adjusted in these multivariable models.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>In the end, 552 patients (34.2%) died, of whom 264 (47.8%) died from CVD mortality, corresponding to incidence rates of 71.18 and 34.04 per 1,000 person-years, respectively. In multivariable analyses, competing risk regression model showed no significant association between NHHR and overall CVD mortality. However, each 1- standard deviation (SD) increase in NHHR level was associated with a 35% higher risk of atherosclerotic CVD mortality (sub-distribution hazard ratio [SHR] 1.35, 95% Confidence interval [CI] 1.17\u20131.56), and a 27% lower risk of non-atherosclerotic CVD mortality (SHR 0.73, 95% CI 0.58\u20130.93), respectively. Cox regression model indicated that each 1-SD increase in NHHR level was independently associated with a 16% increase in all-cause mortality (HR 1.16, 95% CI 1.06\u20131.26). Quartile-based analysis reinforced these findings.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>An elevated NHHR level conferred an increased risk of atherosclerotic CVD and all-cause mortality, yet showed a paradoxical association with reduced non-atherosclerotic CVD mortality in PD patients.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fnut.2026.1827345","type":"journal-article","created":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T05:48:16Z","timestamp":1783403296000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":2,"title":["Association of non-high-density lipoprotein cholesterol to high-density lipoprotein cholesterol ratio (NHHR) with cardiovascular mortality in peritoneal dialysis patients: a prospective cohort study"],"prefix":"10.3389","volume":"13","author":[{"given":"Yuening","family":"Zhang","sequence":"first","affiliation":[{"name":"Department of Nephrology, The First Affiliated Hospital, Sun Yat-sen University","place":["Guangzhou, China"]},{"name":"Key Laboratory of Nephrology, Ministry of Health and Guangdong Province","place":["Guangzhou, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junjie","family":"Liang","sequence":"additional","affiliation":[{"name":"Department of Nephrology, The First Affiliated Hospital, Sun Yat-sen University","place":["Guangzhou, China"]},{"name":"Key Laboratory of Nephrology, Ministry of Health and Guangdong Province","place":["Guangzhou, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suchun","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Nephrology, The First Affiliated Hospital, Sun Yat-sen University","place":["Guangzhou, China"]},{"name":"Key Laboratory of Nephrology, Ministry of Health and Guangdong Province","place":["Guangzhou, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kexin","family":"Ma","sequence":"additional","affiliation":[{"name":"Department of Nephrology, The First Affiliated Hospital, Sun Yat-sen University","place":["Guangzhou, China"]},{"name":"Key Laboratory of Nephrology, Ministry of Health and Guangdong Province","place":["Guangzhou, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dandan","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Nephrology, The First Affiliated Hospital, Sun Yat-sen University","place":["Guangzhou, China"]},{"name":"Key Laboratory of Nephrology, Ministry of Health and Guangdong Province","place":["Guangzhou, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Chen","sequence":"additional","affiliation":[{"name":"Department of Nephrology, The First Affiliated Hospital, Sun Yat-sen University","place":["Guangzhou, China"]},{"name":"Key Laboratory of Nephrology, Ministry of Health and Guangdong Province","place":["Guangzhou, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qinghua","family":"Liu","sequence":"additional","affiliation":[{"name":"Department of Nephrology, The First Affiliated Hospital, Sun Yat-sen University","place":["Guangzhou, China"]},{"name":"Key Laboratory of Nephrology, Ministry of Health and Guangdong Province","place":["Guangzhou, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Yu","sequence":"additional","affiliation":[{"name":"Department of Nephrology, The First Affiliated Hospital, Sun Yat-sen University","place":["Guangzhou, China"]},{"name":"Key Laboratory of Nephrology, Ministry of Health and Guangdong Province","place":["Guangzhou, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,7,7]]},"reference":[{"key":"ref1","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1016\/s0735-1097(01)01781-8","article-title":"Cardiac calcification in adult hemodialysis patients. A link between end-stage renal disease and cardiovascular disease?","volume":"39","author":"Raggi","year":"2002","journal-title":"J Am Coll Cardiol"},{"key":"ref2","doi-asserted-by":"publisher","first-page":"327","DOI":"10.3400\/avd.ra.17-00051","article-title":"Cardiovascular disease in patients with end-stage renal disease on hemodialysis","volume":"10","author":"Aoki","year":"2017","journal-title":"Ann Vasc Dis"},{"key":"ref3","doi-asserted-by":"publisher","first-page":"E40","DOI":"10.1111\/chf.12030","article-title":"Uremic cardiomyopathy: an underdiagnosed disease","volume":"19","author":"Alhaj","year":"2013","journal-title":"Congest Heart Fail"},{"key":"ref4","doi-asserted-by":"publisher","first-page":"737","DOI":"10.1161\/01.atv.8.6.737","article-title":"High density lipoprotein cholesterol and mortality. The Framingham heart study","volume":"8","author":"Wilson","year":"1988","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"ref5","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1001\/jama.294.3.326","article-title":"Non-HDL cholesterol, apolipoproteins A-I and B100, standard lipid measures, lipid ratios, and CRP as risk factors for cardiovascular disease in women","volume":"294","author":"Ridker","year":"2005","journal-title":"JAMA"},{"key":"ref6","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1681\/ASN.2006060674","article-title":"Inverse association between lipid levels and mortality in men with chronic kidney disease who are not yet on dialysis: effects of case mix and the malnutrition-inflammation-Cachexia syndrome","volume":"18","author":"Kovesdy","year":"2007","journal-title":"J Am Soc Nephrol"},{"key":"ref7","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1038\/nrneph.2012.33","article-title":"Statins in the management of dyslipidemia associated with chronic kidney disease","volume":"8","author":"Epstein","year":"2012","journal-title":"Nat Rev Nephrol"},{"key":"ref8","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1007\/s40265-025-02275-w","article-title":"Lipid-lowering therapies in patients with chronic kidney disease: a perspective on high-density lipoprotein cholesterol","volume":"86","author":"Naim","year":"2026","journal-title":"Drugs"},{"key":"ref9","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1016\/j.atherosclerosis.2011.10.038","article-title":"Oxidized high-density lipoprotein as a risk factor for cardiovascular events in prevalent hemodialysis patients","volume":"220","author":"Honda","year":"2012","journal-title":"Atherosclerosis"},{"key":"ref10","doi-asserted-by":"publisher","first-page":"1784","DOI":"10.2215\/CJN.00730116","article-title":"High density lipoprotein cholesterol and the risk of all-cause mortality among U.S. veterans","volume":"11","author":"Bowe","year":"2016","journal-title":"Clin J Am Soc Nephrol"},{"key":"ref11","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1186\/s12944-025-02555-0","article-title":"Association between non-high-density lipoprotein cholesterol to high-density lipoprotein cholesterol ratio and cerebral atherosclerotic stenosis: a retrospective study","volume":"24","author":"Han","year":"2025","journal-title":"Lipids Health Dis"},{"key":"ref12","doi-asserted-by":"publisher","first-page":"1112","DOI":"10.2215\/CJN.09961110","article-title":"Elevated non-high-density lipoprotein cholesterol (non-HDL-C) predicts atherosclerotic cardiovascular events in hemodialysis patients","volume":"6","author":"Shoji","year":"2011","journal-title":"Clin J Am Soc Nephrol"},{"key":"ref13","doi-asserted-by":"publisher","first-page":"e009096","DOI":"10.1161\/JAHA.118.009096","article-title":"Inverse association between serum non-high-density lipoprotein cholesterol levels and mortality in patients undergoing incident hemodialysis","volume":"7","author":"Chang","year":"2018","journal-title":"J Am Heart Assoc"},{"key":"ref14","doi-asserted-by":"publisher","first-page":"732","DOI":"10.1016\/j.jacl.2021.06.005","article-title":"Non-high-density lipoprotein cholesterol and mortality among peritoneal dialysis patients","volume":"15","author":"Yu","year":"2021","journal-title":"J Clin Lipidol"},{"key":"ref15","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1186\/s12944-024-02219-5","article-title":"Association of 28-day mortality with non-high-density lipoprotein cholesterol and the high-density lipoprotein cholesterol ratio (NHHR) in patients with sepsis: results of MIMIC-IV database analysis","volume":"23","author":"Zhang","year":"2024","journal-title":"Lipids Health Dis"},{"key":"ref16","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1111\/dom.16018","article-title":"Association of non-high-density lipoprotein cholesterol\/high-density lipoprotein cholesterol ratio with cardiovascular outcomes in patients with type 2 diabetes mellitus: evidence from the ACCORD cohort","volume":"27","author":"Liu","year":"2025","journal-title":"Diabetes Obes Metab"},{"key":"ref17","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1186\/s12944-024-02309-4","article-title":"Association between the non-high-density lipoprotein cholesterol to high-density lipoprotein cholesterol ratio (NHHR) and cardiovascular outcomes in patients undergoing percutaneous coronary intervention: a retrospective study","volume":"23","author":"Liu","year":"2024","journal-title":"Lipids Health Dis"},{"key":"ref18","doi-asserted-by":"publisher","first-page":"1235","DOI":"10.2147\/CIA.S461150","article-title":"The predictive value of atherogenic index of plasma, non- high density lipoprotein cholesterol (non-HDL-C), non-HDL-C\/HDL-C, and lipoprotein combine index for stroke incidence and prognosis in maintenance hemodialysis patients","volume":"19","author":"Ma","year":"2024","journal-title":"Clin Interv Aging"},{"key":"ref19","doi-asserted-by":"publisher","first-page":"767","DOI":"10.1007\/s10157-012-0615-5","article-title":"Serum non-high-density lipoprotein cholesterol (non-HDL-C) levels and cardiovascular mortality in chronic hemodialysis patients","volume":"16","author":"Echida","year":"2012","journal-title":"Clin Exp Nephrol"},{"key":"ref20","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1186\/s12882-020-01993-5","article-title":"Elevated TG\/HDL-C and non-HDL-C\/HDL-C ratios predict mortality in peritoneal dialysis patients","volume":"21","author":"Xia","year":"2020","journal-title":"BMC Nephrol"},{"key":"ref21","doi-asserted-by":"publisher","first-page":"2299601","DOI":"10.1080\/0886022X.2023.2299601","article-title":"Association of albumin to non-high-density lipoprotein cholesterol ratio with mortality in peritoneal dialysis patients","volume":"46","author":"Xie","year":"2024","journal-title":"Ren Fail"},{"key":"ref22","doi-asserted-by":"publisher","first-page":"801979","DOI":"10.3389\/fnut.2022.801979","article-title":"Association of ratio of apolipoprotein B to apolipoprotein A1 with survival in peritoneal dialysis","volume":"9","author":"Yu","year":"2022","journal-title":"Front Nutr"},{"key":"ref23","first-page":"829","article-title":"Impact of renal function on the effects of LDL cholesterol lowering with statin-based regimens: a meta-analysis of individual participant data from 28 randomized trials","volume-title":"Lancet Diabetes Endocrinol","author":"Herrington","year":"2016"},{"key":"ref24","doi-asserted-by":"publisher","first-page":"604","DOI":"10.7326\/0003-4819-150-9-200905050-00006","article-title":"A new equation to estimate glomerular filtration rate","volume":"150","author":"Levey","year":"2009","journal-title":"Ann Intern Med"},{"key":"ref25","doi-asserted-by":"publisher","first-page":"e254","DOI":"10.1161\/CIR.0000000000000950","article-title":"Heart disease and stroke statistics\u20142021 update","volume":"143","author":"Virani","year":"2021","journal-title":"Circulation"},{"key":"ref26","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1186\/s12882-020-01984-6","article-title":"Plasma fibrinogen and mortality in patients undergoing peritoneal dialysis: a prospective cohort study","volume":"21","author":"Yu","year":"2020","journal-title":"BMC Nephrol"},{"key":"ref27","doi-asserted-by":"publisher","first-page":"496","DOI":"10.1080\/01621459.1999.10474144","article-title":"A proportional hazards model for the subdistribution of a competing risk","volume":"94","author":"Fine","year":"1999","journal-title":"J Am Stat Assoc"},{"key":"ref28","doi-asserted-by":"publisher","first-page":"A7","DOI":"10.1053\/j.ajkd.2016.12.004","article-title":"US renal data system 2016 annual data report: epidemiology of kidney disease in the United States","volume":"69","author":"Saran","year":"2017","journal-title":"Am J Kidney Dis"},{"key":"ref29","doi-asserted-by":"publisher","first-page":"703","DOI":"10.1016\/j.jcmg.2013.09.025","article-title":"Defining the natural history of uremic cardiomyopathy in chronic kidney disease: the role of cardiovascular magnetic resonance","volume":"7","author":"Edwards","year":"2014","journal-title":"JACC Cardiovasc Imaging"},{"key":"ref30","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1111\/j.1523-1755.2005.00086.x","article-title":"Clinical and pathologic characteristics of dilated cardiomyopathy in hemodialysis patients","volume":"67","author":"Aoki","year":"2005","journal-title":"Kidney Int"},{"key":"ref31","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1177\/089686080002000307","article-title":"Dyslipidemia in peritoneal dialysis\u2014relation to dialytic variables","volume":"20","author":"Johansson","year":"2000","journal-title":"Perit Dial Int"},{"key":"ref32","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1177\/089686080202200209","article-title":"Alterations in lipoprotein composition in peritoneal dialysis patients","volume":"22","author":"Moberly","year":"2002","journal-title":"Perit Dial Int"},{"key":"ref33","doi-asserted-by":"publisher","first-page":"164","DOI":"10.12997\/jla.2023.12.2.164","article-title":"Higher non-high-density lipoprotein cholesterol was higher associated with cardiovascular disease comparing higher LDL-C in nine years follow up: cohort study","volume":"12","author":"Hong","year":"2023","journal-title":"J Lipid Atheroscler"},{"key":"ref34","doi-asserted-by":"publisher","first-page":"1000","DOI":"10.1016\/j.kint.2017.09.011","article-title":"Lowering LDL cholesterol reduces cardiovascular risk independently of presence of inflammation","volume":"93","author":"Storey","year":"2018","journal-title":"Kidney Int"},{"key":"ref35","doi-asserted-by":"publisher","first-page":"47","DOI":"10.2215\/CJN.07320619","article-title":"Apolipoprotein B, triglyceride-rich lipoproteins, and risk of cardiovascular events in persons with CKD","volume":"15","author":"Lamprea-Montealegre","year":"2020","journal-title":"Clin J Am Soc Nephrol"},{"key":"ref36","doi-asserted-by":"publisher","first-page":"731","DOI":"10.1152\/japplphysiol.00226.2025","article-title":"Elevated LDL-C induces T-cell metabolic dysfunction and increases inflammation and oxidative stress in midlife adults","volume":"139","author":"DeConne","year":"1985","journal-title":"J Appl Physiol"},{"key":"ref37","doi-asserted-by":"publisher","first-page":"H481","DOI":"10.1152\/ajpheart.00434.2020","article-title":"Cardiometabolic risk factors are associated with immune cell mitochondrial respiration in humans","volume":"319","author":"DeConne","year":"2020","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"ref38","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1186\/s12916-019-1433-3","article-title":"Does low-density lipoprotein cholesterol induce inflammation? If so, does it matter? Current insights and future perspectives for novel therapies","volume":"17","author":"Jukema","year":"2019","journal-title":"BMC Med"},{"key":"ref39","doi-asserted-by":"publisher","first-page":"H265","DOI":"10.1152\/ajpheart.00509.2016","article-title":"L5-LDL from ST-elevation myocardial infarction patients induces IL-1\u03b2 production via LOX-1 and NLRP3 inflammasome activation in macrophages","volume":"312","author":"Yang","year":"2017","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"ref40","doi-asserted-by":"publisher","first-page":"1899","DOI":"10.1194\/jlr.P068015","article-title":"The relationship between non-HDL cholesterol and macrophage phenotypes in human adipose tissue","volume":"57","author":"Poledne","year":"2016","journal-title":"J Lipid Res"},{"key":"ref41","doi-asserted-by":"publisher","first-page":"1357","DOI":"10.1038\/nature08938","article-title":"NLRP3 inflammasomes are required for atherogenesis and activated by cholesterol crystals","volume":"464","author":"Duewell","year":"2010","journal-title":"Nature"},{"key":"ref42","doi-asserted-by":"publisher","first-page":"e11765","DOI":"10.1371\/journal.pone.0011765","article-title":"Cholesterol crystals activate the NLRP3 inflammasome in human macrophages: a novel link between cholesterol metabolism and inflammation","volume":"5","author":"Rajam\u00e4ki","year":"2010","journal-title":"PLoS One"},{"key":"ref43","doi-asserted-by":"publisher","first-page":"12040","DOI":"10.1073\/pnas.90.24.12040","article-title":"In vivo protection against endotoxin by plasma high density lipoprotein","volume":"90","author":"Levine","year":"1993","journal-title":"Proc Natl Acad Sci USA"},{"key":"ref44","doi-asserted-by":"publisher","first-page":"1601","DOI":"10.1084\/jem.184.5.1601","article-title":"Antiinflammatory effects of reconstituted high-density lipoprotein during human endotoxemia","volume":"184","author":"Pajkrt","year":"1996","journal-title":"J Exp Med"},{"key":"ref45","doi-asserted-by":"publisher","first-page":"101445","DOI":"10.1016\/j.bbrep.2023.101445","article-title":"ApoM binds endotoxin contributing to neutralization and clearance by high density lipoprotein","volume":"34","author":"Mousa","year":"2023","journal-title":"Biochem Biophys Rep"},{"key":"ref46","doi-asserted-by":"publisher","first-page":"615996","DOI":"10.3389\/fcell.2020.615996","article-title":"Direct regulation of the T cell antigen receptor\u2019s activity by cholesterol","volume":"8","author":"Pathan-Chhatbar","year":"2020","journal-title":"Front Cell Dev Biol"},{"key":"ref47","doi-asserted-by":"publisher","first-page":"e38733","DOI":"10.1371\/journal.pone.0038733","article-title":"Increased membrane cholesterol in lymphocytes diverts T-cells toward an inflammatory response","volume":"7","author":"Surls","year":"2012","journal-title":"PLoS One"},{"key":"ref48","doi-asserted-by":"publisher","first-page":"9613","DOI":"10.1073\/pnas.1103187108","article-title":"Endothelium-protective sphingosine-1-phosphate provided by HDL-associated apolipoprotein M","volume":"108","author":"Christoffersen","year":"2011","journal-title":"Proc Natl Acad Sci USA"},{"key":"ref49","doi-asserted-by":"publisher","first-page":"ra79","DOI":"10.1126\/scisignal.aaa2581","article-title":"HDL-bound sphingosine 1-phosphate acts as a biased agonist for the endothelial cell receptor S1P1 to limit vascular inflammation","volume":"8","author":"Galvani","year":"2015","journal-title":"Sci Signal"},{"key":"ref50","doi-asserted-by":"publisher","first-page":"2381","DOI":"10.1182\/blood.v97.8.2381","article-title":"Apolipoprotein A-I inhibits the production of interleukin-1beta and tumor necrosis factor-alpha by blocking contact-mediated activation of monocytes by T lymphocytes","volume":"97","author":"Hyka","year":"2001","journal-title":"Blood"},{"key":"ref51","doi-asserted-by":"publisher","first-page":"430","DOI":"10.3390\/antiox14040430","article-title":"How does HDL participate in atherogenesis? Antioxidant activity versus role in reverse cholesterol transport","volume":"14","author":"Durrington","year":"2025","journal-title":"Antioxidants (Basel)"},{"key":"ref52","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1016\/j.bbacli.2017.07.002","article-title":"Antioxidative activity of high-density lipoprotein (HDL): mechanistic insights into potential clinical benefit","volume":"8","author":"Brites","year":"2017","journal-title":"BBA Clin"}],"container-title":["Frontiers in Nutrition"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fnut.2026.1827345\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T05:48:17Z","timestamp":1783403297000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fnut.2026.1827345\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,7]]},"references-count":52,"alternative-id":["10.3389\/fnut.2026.1827345"],"URL":"https:\/\/doi.org\/10.3389\/fnut.2026.1827345","relation":{},"ISSN":["2296-861X"],"issn-type":[{"value":"2296-861X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,7]]},"article-number":"1827345"}}